In the past 5 years publicly funded research organisations in Australia and New Zealand have achieved AU$1.6B in commercialisation deals with 266 new companies created in Australia and 68 new companies created in New Zealand.
Those numbers from KCA’s SCOPR™ 2022, the Survey of Commercialisation Outcomes from Public Research from 64 participating universities and research institutes in Australia and New Zealand show success in the commercialisation of publicly funded research, achieving positive impact in society in a wide range of technologies from life sciences through to MedTech, IT and engineering solutions.
The 2022 Report for this year highlights:
- New Companies Created – 49 in Australia and 18 in New Zealand
- Commercialisation Income – AU$307M in Australia and NZ$155M in New Zealand
- Industry Contracts – AU$934M in Australia and NZ$178M in New Zealand
- Commercial Deals – 836 in Australia and 97 in New Zealand
SCOPR® is conducted every year by Knowledge Commercialisation Australasia (KCA) who engages gemaker to collect and analyse the data from Australian and New Zealand universities and research agencies.
In 2023, KCA entered into a strategic partnership with the Australian Government Department of Education with the aims of improving response rates for SCOPR® and achieving enhancements to survey questions. As part of this partnership, a joint workshop was held with organisations including AAMRI, NHMRC, ARC, Universities Australia and the Department of Industry, Science and Resources.
Participation in SCOPR® is voluntary, and the metrics are supplied on a self-reporting basis. In 2022, 64 Australian and New Zealand research organisations participated, an increase of 31% on last year’s participation.
“It is very pleasing to see the significant increase of participation of organisations for 2022” KCA Chair Quin Chang said, “This increase confirms the value of the survey both to individual organisations and to the wider community”.
SCOPR is overseen by a committee chaired by Mr John Grace AO, with support of expert professionals to conduct the survey. KCA’s role is to enable individual organisations assess their research performance while the aggregate commercialisation metrics emerging from the survey results help to highlight their economic contribution and inform policy development.
